Ariadna Zybek-Kocik
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ariadna Zybek-Kocik has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Marek Ruchała
Department of Endocrinology, Metabolism and Internal Medicine, Poznań University of Medical Sciences 1
10 shared publications - Ewelina Szczepanek-Parulska
Department of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, 61-701 Poznan, Poland
4 shared publications - Przemysław Guzik
Department of Cardiology-Intensive Therapy and Internal Medicine, Poznan University of Medical Sciences, Poznan, Poland
3 shared publications - Michał Pytka
Department of Cardiology - Intensive Therapy, Poznan University of Medical Sciences, Poznan, Poland
2 shared publications Tomasz Krauze
Department of Cardiology-Intensive Therapy and Internal Medicine, Poznan University of Medical Sciences, Poznan, Poland
2 shared publications- Abikasinee Erampamoorthy
Department of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, 61-701 Poznan, Poland
1 shared publication
Latest Publications
- Open Access
- 6 May 2026
- Published by Springer Nature in Journal of Endocrinological Investigation
- Vol. 49 (8) , 1931-1942
Comparative analysis of PTH Washout and 99mTc-MIBI SPECT/CT in presurgical localization for patients with primary hyperparathyroidism
Purpose: Our study aimed to evaluate the performance and concordance of parathyroid hormone wash-out (PTHw) and 99m Tc-MIBI+SPECT/CT (MIBI) in preoperative localization for patients with primary hyperparathyroidism (PHPT), and assess potential factors influencing their diagnostic utility including patient characteristics, lesion size and comorbidities. Methods: This was a real-life, retrospective study involving 125 participants, who underwent ultrasound-guided fine needle aspiration biopsy with PTHw determined by electrochemiluminescence (Elecsys analyser) and subtraction scintigraphy together with SPECT/CT images. Results: PTHw was positive in 84.8% and MIBI in 84.0% of cases, with concordant findings in 73.6% of patients. In MIBI-negative cases, PTHw accurately localized PA in 70.0%, while MIBI identified lesions in 68.4% of PTHw-negative cases. Larger lesions were associated with improved performance for both techniques, although a significant size-dependent effect (≥10 mm) was observed only for MIBI (χ 2 = 3.92, p = 0.048; φ = -0.18). The right inferior gland was the most frequent lesion location detected by PTHw (28.0%). PTHw correlated positively with serum PTH (r=0.29), PTHw-to-serum PTH ratio (r=0.84), total calcium (r=0.27), ionized calcium (r=0.31) and alkaline phosphatase (r=0.31), and inversely with phosphate (r = -0.22) and vitamin D (r= -0.20). Conclusion: Our findings reinforce the complementary role of ultrasound-guided parathyroid hormone washout and 99m Tc-MIBI with SPECT/CT, in the preoperative PHPT imaging diagnostics, particularly when one modality yields negative or inconclusive results. Additionally, our results highlight the need for individualized imaging strategies based on specific patient profiles. Larger prospective studies with histopathological verification are warranted to corroborate these observations and refine preoperative localization protocols.
- 6 May 2026
- Published by Springer Nature in Journal of Endocrinological Investigation
- Vol. 49 (8) , 1931-1942
Open AccessComparative analysis of PTH Washout and 99mTc-MIBI SPECT/CT in presurgical localization for patients with primary hyperparathyroidism
Purpose: Our study aimed to evaluate the performance and concordance of parathyroid hormone wash-out (PTHw) and 99m Tc-MIBI+SPECT/CT (MIBI) in preoperative localization for patients with primary hyperparathyroidism (PHPT), and assess potential factors influencing their diagnostic utility including patient characteristics, lesion size and comorbidities. Methods: This was a real-life, retrospective study involving 125 participants, who underwent ultrasound-guided fine needle aspiration biopsy with PTHw determined by electrochemiluminescence (Elecsys analyser) and subtraction scintigraphy together with SPECT/CT images. Results: PTHw was positive in 84.8% and MIBI in 84.0% of cases, with concordant findings in 73.6% of patients. In MIBI-negative cases, PTHw accurately localized PA in 70.0%, while MIBI identified lesions in 68.4% of PTHw-negative cases. Larger lesions were associated with improved performance for both techniques, although a significant size-dependent effect (≥10 mm) was observed only for MIBI (χ 2 = 3.92, p = 0.048; φ = -0.18). The right inferior gland was the most frequent lesion location detected by PTHw (28.0%). PTHw correlated positively with serum PTH (r=0.29), PTHw-to-serum PTH ratio (r=0.84), total calcium (r=0.27), ionized calcium (r=0.31) and alkaline phosphatase (r=0.31), and inversely with phosphate (r = -0.22) and vitamin D (r= -0.20). Conclusion: Our findings reinforce the complementary role of ultrasound-guided parathyroid hormone washout and 99m Tc-MIBI with SPECT/CT, in the preoperative PHPT imaging diagnostics, particularly when one modality yields negative or inconclusive results. Additionally, our results highlight the need for individualized imaging strategies based on specific patient profiles. Larger prospective studies with histopathological verification are warranted to corroborate these observations and refine preoperative localization protocols.
- Open Access
- 4 December 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (23) , 15303
ATPase Inhibitory Factor 1—A Novel Marker of Cellular Fitness and Exercise Capacity?
ATPase inhibitory factor 1 is a myokine inhibiting the hydrolytic activity of mitochondrial adenosine triphosphate synthase and ecto-F1-ATPase on the surface of many cells. IF1 affects ATP metabolism in mitochondria and the extracellular space and upregulates glucose uptake in myocytes; these processes are essential in physical activity. It is unknown whether the IF1 serum concentration is associated with exercise capacity. This study explored the association between resting IF1 serum concentration and exercise capacity indices in healthy people. IF1 serum concentration was measured in samples collected at rest in 97 healthy amateur cyclists. Exercise capacity was assessed on a bike ergometer at the successive stages of the progressive cardiopulmonary exercise test (CPET). IF1 serum concentration was negatively and significantly correlated with oxygen consumption, oxygen pulse, and load at various CPET stages. A better exercise capacity was associated with lower circulating IF1. IF1 may reflect better cellular/mitochondrial energetic fitness, but there is uncertainty regarding how IF1 is released into the intravascular space. We speculate that lower IF1 concentration may reflect a better cellular/mitochondrial integrity, as this protein is bound more strongly with ATPases in mitochondria and cellular surfaces in people with higher exercise capacity.
- 4 December 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (23) , 15303
Open AccessATPase Inhibitory Factor 1—A Novel Marker of Cellular Fitness and Exercise Capacity?
ATPase inhibitory factor 1 is a myokine inhibiting the hydrolytic activity of mitochondrial adenosine triphosphate synthase and ecto-F1-ATPase on the surface of many cells. IF1 affects ATP metabolism in mitochondria and the extracellular space and upregulates glucose uptake in myocytes; these processes are essential in physical activity. It is unknown whether the IF1 serum concentration is associated with exercise capacity. This study explored the association between resting IF1 serum concentration and exercise capacity indices in healthy people. IF1 serum concentration was measured in samples collected at rest in 97 healthy amateur cyclists. Exercise capacity was assessed on a bike ergometer at the successive stages of the progressive cardiopulmonary exercise test (CPET). IF1 serum concentration was negatively and significantly correlated with oxygen consumption, oxygen pulse, and load at various CPET stages. A better exercise capacity was associated with lower circulating IF1. IF1 may reflect better cellular/mitochondrial energetic fitness, but there is uncertainty regarding how IF1 is released into the intravascular space. We speculate that lower IF1 concentration may reflect a better cellular/mitochondrial integrity, as this protein is bound more strongly with ATPases in mitochondria and cellular surfaces in people with higher exercise capacity.
- Open Access
- 7 April 2022
- Published by MDPI AG in Metabolites
- Vol. 12 (4) , 336
The Role of Thyroid Hormones on Skeletal Muscle Thermogenesis
Nowadays obesity becomes a significant global problem. Hence, recently more and more attention has been paid to substances present in the body that have a significant impact on metabolic processes and thermogenesis, in the context of their potential use in the prevention and treatment of obesity. It is well known that the relationship between thyroid hormones and obesity is multilayered, however recently, more and more information about the possible relation between thyroid hormones and muscle metabolism has been published. The aim of this review is to present the most updated information on the physiological impact of thyroid hormones on muscle tissue, as well as pathological changes related to the occurrence of various types of thyroid disorders, including hypothyroidism, hyperthyroidism and sick euthyroid syndrome. However, the data in humans still remains insufficient, and further studies are needed to fully explore the thyroid-muscle cross-talk.
- 7 April 2022
- Published by MDPI AG in Metabolites
- Vol. 12 (4) , 336
Open AccessThe Role of Thyroid Hormones on Skeletal Muscle Thermogenesis
Nowadays obesity becomes a significant global problem. Hence, recently more and more attention has been paid to substances present in the body that have a significant impact on metabolic processes and thermogenesis, in the context of their potential use in the prevention and treatment of obesity. It is well known that the relationship between thyroid hormones and obesity is multilayered, however recently, more and more information about the possible relation between thyroid hormones and muscle metabolism has been published. The aim of this review is to present the most updated information on the physiological impact of thyroid hormones on muscle tissue, as well as pathological changes related to the occurrence of various types of thyroid disorders, including hypothyroidism, hyperthyroidism and sick euthyroid syndrome. However, the data in humans still remains insufficient, and further studies are needed to fully explore the thyroid-muscle cross-talk.
- 26 February 2021
- Published by VM Media Group sp. z o.o in Endokrynologia Polska
- Vol. 72 (1) , 1-7
Titin and dystrophin serum concentration changes in patients affected by thyroid disorders
Objective: It is well established, that thyroid hormones significantly affect skeletal muscles function, causing symptoms like myalgia and muscle weakness. Hypothyroid patients present increased levels of creatine kinase (CK), indicating muscle destruction. Lately, we proposed new serum markers of muscle disturbances in thyroid disorders - titin (TTN) and dystrophin (DMD). The aim of this study is to determine the association between thyroid status, muscle metabolism and serum levels of TTN and DMD in patients affected by hypo- and hyperthyroidism, before and after the treatment. Design and patients: In the study 56 subjects were enrolled. The studied group consisted of 16 patients with newly diagnosed overt hypothyroidism and 20 patients with hyperthyroidism. 20 healthy controls were also included in the study. Body composition, thyroid hormones and biochemical markers of muscle deterioration levels were evaluated before and after restoration of euthyroidism. Results: DMD and TTN levels were noticeably lower in the hypothyroid group and hyperthyroid group in comparison with controls, at the border of statistical significance. Along with the thyroid hormones and CK normalization, DMD levels increased in hypothyroid group, with no significant lowering of TTN levels. However, TTN concentrations and fT3/fT4 ratio became significantly lower than in controls. Hyperthyroid patients experienced no significant changes in TTN and DMD. Conclusions: Presented data indicates, TTN and DMD might be the potential new markers of musculoskeletal deterioration in thyroid disorders. In addition, the shift in TTN and DMD serum concentrations after the treatment of hypothyroidism accompanied by decreased fT3/fT4 ratio may suggest the influence of chosen therapeutic approach on muscle metabolism. Objective: It is well established, that thyroid hormones significantly affect skeletal muscles function, causing symptoms like myalgia and muscle weakness. Hypothyroid patients present increased levels of creatine kinase (CK), indicating muscle destruction. Lately, we proposed new serum markers of muscle disturbances in thyroid disorders - titin (TTN) and dystrophin (DMD). The aim of this study is to determine the association between thyroid status, muscle metabolism and serum levels of TTN and DMD in patients affected by hypo- and hyperthyroidism, before and after the treatment. Design and patients: In the study 56 subjects were enrolled. The studied group consisted of 16 patients with newly diagnosed overt hypothyroidism and 20 patients with hyperthyroidism. 20 healthy controls were also included in the study. Body composition, thyroid hormones and biochemical markers of muscle deterioration levels were evaluated before and after restoration of euthyroidism. Results: DMD and TTN levels were noticeably lower in the hypothyroid group and hyperthyroid group in comparison with controls, at the border of statistical significance. Along with the thyroid hormones and CK normalization, DMD levels increased in hypothyroid group, with no significant lowering of TTN levels. However, TTN concentrations and fT3/fT4 ratio became significantly lower than in controls. Hyperthyroid patients experienced no significant changes in TTN and DMD. Conclusions: Presented data indicates, TTN and DMD might be the potential new markers of musculoskeletal deterioration in thyroid disorders. In addition, the shift in TTN and DMD serum concentrations after the treatment of hypothyroidism accompanied by decreased fT3/fT4 ratio may suggest the influence of chosen therapeutic approach on muscle metabolism.
- 26 February 2021
- Published by VM Media Group sp. z o.o in Endokrynologia Polska
- Vol. 72 (1) , 1-7
Titin and dystrophin serum concentration changes in patients affected by thyroid disorders
Objective: It is well established, that thyroid hormones significantly affect skeletal muscles function, causing symptoms like myalgia and muscle weakness. Hypothyroid patients present increased levels of creatine kinase (CK), indicating muscle destruction. Lately, we proposed new serum markers of muscle disturbances in thyroid disorders - titin (TTN) and dystrophin (DMD). The aim of this study is to determine the association between thyroid status, muscle metabolism and serum levels of TTN and DMD in patients affected by hypo- and hyperthyroidism, before and after the treatment. Design and patients: In the study 56 subjects were enrolled. The studied group consisted of 16 patients with newly diagnosed overt hypothyroidism and 20 patients with hyperthyroidism. 20 healthy controls were also included in the study. Body composition, thyroid hormones and biochemical markers of muscle deterioration levels were evaluated before and after restoration of euthyroidism. Results: DMD and TTN levels were noticeably lower in the hypothyroid group and hyperthyroid group in comparison with controls, at the border of statistical significance. Along with the thyroid hormones and CK normalization, DMD levels increased in hypothyroid group, with no significant lowering of TTN levels. However, TTN concentrations and fT3/fT4 ratio became significantly lower than in controls. Hyperthyroid patients experienced no significant changes in TTN and DMD. Conclusions: Presented data indicates, TTN and DMD might be the potential new markers of musculoskeletal deterioration in thyroid disorders. In addition, the shift in TTN and DMD serum concentrations after the treatment of hypothyroidism accompanied by decreased fT3/fT4 ratio may suggest the influence of chosen therapeutic approach on muscle metabolism. Objective: It is well established, that thyroid hormones significantly affect skeletal muscles function, causing symptoms like myalgia and muscle weakness. Hypothyroid patients present increased levels of creatine kinase (CK), indicating muscle destruction. Lately, we proposed new serum markers of muscle disturbances in thyroid disorders - titin (TTN) and dystrophin (DMD). The aim of this study is to determine the association between thyroid status, muscle metabolism and serum levels of TTN and DMD in patients affected by hypo- and hyperthyroidism, before and after the treatment. Design and patients: In the study 56 subjects were enrolled. The studied group consisted of 16 patients with newly diagnosed overt hypothyroidism and 20 patients with hyperthyroidism. 20 healthy controls were also included in the study. Body composition, thyroid hormones and biochemical markers of muscle deterioration levels were evaluated before and after restoration of euthyroidism. Results: DMD and TTN levels were noticeably lower in the hypothyroid group and hyperthyroid group in comparison with controls, at the border of statistical significance. Along with the thyroid hormones and CK normalization, DMD levels increased in hypothyroid group, with no significant lowering of TTN levels. However, TTN concentrations and fT3/fT4 ratio became significantly lower than in controls. Hyperthyroid patients experienced no significant changes in TTN and DMD. Conclusions: Presented data indicates, TTN and DMD might be the potential new markers of musculoskeletal deterioration in thyroid disorders. In addition, the shift in TTN and DMD serum concentrations after the treatment of hypothyroidism accompanied by decreased fT3/fT4 ratio may suggest the influence of chosen therapeutic approach on muscle metabolism.
- Open Access
- 31 January 2021
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 18 (3) , 1261
Effect of Various Exercise Regimens on Selected Exercise-Induced Cytokines in Healthy People
Different forms of physical activity—endurance, resistance or dynamic power—stimulate cytokine release from various tissues to the bloodstream. Receptors for exercise-induced cytokines are present in muscle tissue, adipose tissue, liver, brain, bones, cardiovascular system, immune system, pancreas, and skin. They have autocrine, paracrine and endocrine activities. Many of them regulate the myocyte growth and differentiation necessary for muscle hypertrophy and myogenesis. They also modify energy homeostasis, lipid, carbohydrate, and protein metabolism, regulate inflammation and exchange information (crosstalk) between remote organs. So far, interleukin 6 and irisin have been the best studied exercise-induced cytokines. However, many more can be grouped into myokines, hepatokines and adipomyokines. This review focuses on the less known exercise-induced cytokines such as myostatin, follistatin, decorin, brain-derived neurotrophic factor, fibroblast growth factor 21 and interleukin 15, and their relation to various forms of exercise, i.e., acute vs. chronic, regular training in healthy people.
- 31 January 2021
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 18 (3) , 1261
Open AccessEffect of Various Exercise Regimens on Selected Exercise-Induced Cytokines in Healthy People
Different forms of physical activity—endurance, resistance or dynamic power—stimulate cytokine release from various tissues to the bloodstream. Receptors for exercise-induced cytokines are present in muscle tissue, adipose tissue, liver, brain, bones, cardiovascular system, immune system, pancreas, and skin. They have autocrine, paracrine and endocrine activities. Many of them regulate the myocyte growth and differentiation necessary for muscle hypertrophy and myogenesis. They also modify energy homeostasis, lipid, carbohydrate, and protein metabolism, regulate inflammation and exchange information (crosstalk) between remote organs. So far, interleukin 6 and irisin have been the best studied exercise-induced cytokines. However, many more can be grouped into myokines, hepatokines and adipomyokines. This review focuses on the less known exercise-induced cytokines such as myostatin, follistatin, decorin, brain-derived neurotrophic factor, fibroblast growth factor 21 and interleukin 15, and their relation to various forms of exercise, i.e., acute vs. chronic, regular training in healthy people.
- 2 December 2017
- Published by Wiley in Clinical Endocrinology
- Vol. 88 (3) , 460-467
The association between irisin and muscle metabolism in different thyroid disorders
Summary: Background: Irisin is a new adipo‐myokine, encoded by the FNDC5 gene. Currently, there is a discussion regarding the relation between thyroid function and irisin concentration. This prospective study assesses the influence of thyrometabolic changes on serum irisin concentration in association with altered muscle metabolism. This is performed on a large cohort of patients affected by severe hypo‐ or hyperthyroidism, as well as by the expression of the FNDC5 gene in thyroid tissue affected by different pathologies.Methods: The study group comprised 119 patients with newly diagnosed severe hyperthyroidism or hypothyroidism, and a control group of 45 healthy subjects. Body composition, serum irisin concentrations, and thyroid‐related hormones, creatine kinase, dystrophin and titin concentrations were evaluated. FNDC5 expression was also analysed in tissue samples from 80 patients with nontoxic multinodular goitre, toxic goitre, Graves’ disease and papillary thyroid cancer.Results: Irisin concentration was lower in patients with prolonged hypothyroidism. There was a tendency towards lower dystrophin and titin concentrations in patients with hypothyroidism and hyperthyroidism. Restoration of euthyroidism in patients with hypothyroidism resulted in a decreased muscle mass with an increase in irisin concentrations, while the hyperthyroid group showed an increase in fat mass. Statistically significant overexpression of FNDC5 gene was found in patients with toxic goitre as compared to Graves’ disease, papillary thyroid cancer and controls.Conclusions: The presented data support the theory that irisin concentration changes are associated with prolonged hypothyroidism and might primarily constitute the result of prolonged myopathy. These changes are most likely not related to the expression of the FNDC5 gene in the thyroid gland.
- 2 December 2017
- Published by Wiley in Clinical Endocrinology
- Vol. 88 (3) , 460-467
The association between irisin and muscle metabolism in different thyroid disorders
Summary: Background: Irisin is a new adipo‐myokine, encoded by the FNDC5 gene. Currently, there is a discussion regarding the relation between thyroid function and irisin concentration. This prospective study assesses the influence of thyrometabolic changes on serum irisin concentration in association with altered muscle metabolism. This is performed on a large cohort of patients affected by severe hypo‐ or hyperthyroidism, as well as by the expression of the FNDC5 gene in thyroid tissue affected by different pathologies.Methods: The study group comprised 119 patients with newly diagnosed severe hyperthyroidism or hypothyroidism, and a control group of 45 healthy subjects. Body composition, serum irisin concentrations, and thyroid‐related hormones, creatine kinase, dystrophin and titin concentrations were evaluated. FNDC5 expression was also analysed in tissue samples from 80 patients with nontoxic multinodular goitre, toxic goitre, Graves’ disease and papillary thyroid cancer.Results: Irisin concentration was lower in patients with prolonged hypothyroidism. There was a tendency towards lower dystrophin and titin concentrations in patients with hypothyroidism and hyperthyroidism. Restoration of euthyroidism in patients with hypothyroidism resulted in a decreased muscle mass with an increase in irisin concentrations, while the hyperthyroid group showed an increase in fat mass. Statistically significant overexpression of FNDC5 gene was found in patients with toxic goitre as compared to Graves’ disease, papillary thyroid cancer and controls.Conclusions: The presented data support the theory that irisin concentration changes are associated with prolonged hypothyroidism and might primarily constitute the result of prolonged myopathy. These changes are most likely not related to the expression of the FNDC5 gene in the thyroid gland.
- Open Access
- 10 October 2014
- Published by VM Media Group sp. z o.o in Endokrynologia Polska
- Vol. 65 (5) , 388-396
Rola radioterapii oczodołów w leczeniu orbitopatii tarczycowej — aktualny stan wiedzy
The treatment of Graves’ orbitopathy (GO) remains a diagnostic and therapeutic challenge for clinicians worldwide. The elimination of risk factors, such as encouraging smoking cessation and achieving euthyroidism, are the most important and usually sufficient treatment methods in most mild cases. A course of selenium may also be beneficial. High-dose systemic corticosteroid therapy remains the first-line therapy in moderate-to-severe orbitopathy; however in some patients such treatment may be insufficient. Radiotherapy for GO has been used for decades and is considered to be effective in active GO, although less than systemic corticosteroids. Unfortunately, there are only eight randomised studies that may be analysed to assess its true effectiveness and applicability. It has been indicated that radiotherapy affects mainly eye motility and soft tissue changes, with almost no influence on exophthalmos. The combination of these two therapies has proven to be even more effective than either treatment alone, especially in subjects with resistant or recurrent GO. Orbital radiotherapy seems to be a safe procedure with few adverse effects observed long after the therapy. It should be avoided in patients with retinopathy, due to diabetes mellitus and hypertension, and in young subjects (< 35 years old). Orbital radiotherapy, as a safe and generally effective second-line therapy, is used in some countries as a supporting method during the second course of systemic corticosteroid therapy, if the response to the first course is unsatisfactory. Further randomised, double-blind studies are needed to confirm fully its clinical usefulness. (Endokrynol Pol 2014; 65 (5): 388–396) The treatment of Graves’ orbitopathy (GO) remains a diagnostic and therapeutic challenge for clinicians worldwide. The elimination of risk factors, such as encouraging smoking cessation and achieving euthyroidism, are the most important and usually sufficient treatment methods in most mild cases. A course of selenium may also be beneficial. High-dose systemic corticosteroid therapy remains the first-line therapy in moderate-to-severe orbitopathy; however in some patients such treatment may be insufficient. Radiotherapy for GO has been used for decades and is considered to be effective in active GO, although less than systemic corticosteroids. Unfortunately, there are only eight randomised studies that may be analysed to assess its true effectiveness and applicability. It has been indicated that radiotherapy affects mainly eye motility and soft tissue changes, with almost no influence on exophthalmos. The combination of these two therapies has proven to be even more effective than either treatment alone, especially in subjects with resistant or recurrent GO. Orbital radiotherapy seems to be a safe procedure with few adverse effects observed long after the therapy. It should be avoided in patients with retinopathy, due to diabetes mellitus and hypertension, and in young subjects (< 35 years old). Orbital radiotherapy, as a safe and generally effective second-line therapy, is used in some countries as a supporting method during the second course of systemic corticosteroid therapy, if the response to the first course is unsatisfactory. Further randomised, double-blind studies are needed to confirm fully its clinical usefulness. (Endokrynol Pol 2014; 65 (5): 388–396)
- 10 October 2014
- Published by VM Media Group sp. z o.o in Endokrynologia Polska
- Vol. 65 (5) , 388-396
Open AccessRola radioterapii oczodołów w leczeniu orbitopatii tarczycowej — aktualny stan wiedzy
The treatment of Graves’ orbitopathy (GO) remains a diagnostic and therapeutic challenge for clinicians worldwide. The elimination of risk factors, such as encouraging smoking cessation and achieving euthyroidism, are the most important and usually sufficient treatment methods in most mild cases. A course of selenium may also be beneficial. High-dose systemic corticosteroid therapy remains the first-line therapy in moderate-to-severe orbitopathy; however in some patients such treatment may be insufficient. Radiotherapy for GO has been used for decades and is considered to be effective in active GO, although less than systemic corticosteroids. Unfortunately, there are only eight randomised studies that may be analysed to assess its true effectiveness and applicability. It has been indicated that radiotherapy affects mainly eye motility and soft tissue changes, with almost no influence on exophthalmos. The combination of these two therapies has proven to be even more effective than either treatment alone, especially in subjects with resistant or recurrent GO. Orbital radiotherapy seems to be a safe procedure with few adverse effects observed long after the therapy. It should be avoided in patients with retinopathy, due to diabetes mellitus and hypertension, and in young subjects (< 35 years old). Orbital radiotherapy, as a safe and generally effective second-line therapy, is used in some countries as a supporting method during the second course of systemic corticosteroid therapy, if the response to the first course is unsatisfactory. Further randomised, double-blind studies are needed to confirm fully its clinical usefulness. (Endokrynol Pol 2014; 65 (5): 388–396) The treatment of Graves’ orbitopathy (GO) remains a diagnostic and therapeutic challenge for clinicians worldwide. The elimination of risk factors, such as encouraging smoking cessation and achieving euthyroidism, are the most important and usually sufficient treatment methods in most mild cases. A course of selenium may also be beneficial. High-dose systemic corticosteroid therapy remains the first-line therapy in moderate-to-severe orbitopathy; however in some patients such treatment may be insufficient. Radiotherapy for GO has been used for decades and is considered to be effective in active GO, although less than systemic corticosteroids. Unfortunately, there are only eight randomised studies that may be analysed to assess its true effectiveness and applicability. It has been indicated that radiotherapy affects mainly eye motility and soft tissue changes, with almost no influence on exophthalmos. The combination of these two therapies has proven to be even more effective than either treatment alone, especially in subjects with resistant or recurrent GO. Orbital radiotherapy seems to be a safe procedure with few adverse effects observed long after the therapy. It should be avoided in patients with retinopathy, due to diabetes mellitus and hypertension, and in young subjects (< 35 years old). Orbital radiotherapy, as a safe and generally effective second-line therapy, is used in some countries as a supporting method during the second course of systemic corticosteroid therapy, if the response to the first course is unsatisfactory. Further randomised, double-blind studies are needed to confirm fully its clinical usefulness. (Endokrynol Pol 2014; 65 (5): 388–396)
- 17 April 2014
- Published by Bioscientifica in Endocrine Abstracts
Irisin - newly discovered adipo-myokine and its association with thyroid function - preliminary study
Introduction: Irisin is a recently reported adipo-myokine. To date, many researchers underline its significant influence on the body metabolism and thermogenesis. Secreted by muscle and adipose tissue irisin promotes a program of subcutaneous white adipose tissue ‘browning’. As a result, heat production and general energy expenditure raise. Irisin is considered to be a potential mediator of the health-promoting role of physical exercises. Its possible compensatory role in metabolic regulation was also suggested. Aim: The main goal of the project is to asses serum irisin concentration in patients with thyroid function impairment and its correlation with creatine kinase (CK) level. Methods: A studied group consisted of 20 patients newly diagnosed with thyroid function impairement at our department. All subjects underwent routine clinical examination, laboratory tests (irisin, thyroid-stimulating hormone – TSH, free thyroxin – FT4 and triiodothyronine – FT3, and CK concentrations), thyroid ultrasound examination. The associations between irisin, TSH, free thyroid hormones, creatine kinase were analyzed statistically. Furthermore, the difference between irisin serum concentration in hypothyroid and hyperthyroid patients was evaluated. Results: The negative correlation between the irisin and TSH level was demonstrated (r=−0.4924, P=0.023), as well as positive correlation between the irisin and FT4 level (r=0.4833, P=0.036). CK level was negatively correlated with irisin, FT4 and FT3 concentrations (r=−0.7272, P=0,014; r=−0.9636, P≤0.0001; r=−0.8838, P=0.0.0007 respectively). The mean serum irisin level was lower in hypothyroid than hyperthyroid patients, at the border of statistical significance (P=0.0726). Conclusions: Obtained results suggest the influence of thyrometabolic state on irisin concentration; lower irisin level was found in patients with hypothyroidism. This might be explained with muscle destruction, demonstrating with high CK level.
- 17 April 2014
- Published by Bioscientifica in Endocrine Abstracts
Irisin - newly discovered adipo-myokine and its association with thyroid function - preliminary study
Introduction: Irisin is a recently reported adipo-myokine. To date, many researchers underline its significant influence on the body metabolism and thermogenesis. Secreted by muscle and adipose tissue irisin promotes a program of subcutaneous white adipose tissue ‘browning’. As a result, heat production and general energy expenditure raise. Irisin is considered to be a potential mediator of the health-promoting role of physical exercises. Its possible compensatory role in metabolic regulation was also suggested. Aim: The main goal of the project is to asses serum irisin concentration in patients with thyroid function impairment and its correlation with creatine kinase (CK) level. Methods: A studied group consisted of 20 patients newly diagnosed with thyroid function impairement at our department. All subjects underwent routine clinical examination, laboratory tests (irisin, thyroid-stimulating hormone – TSH, free thyroxin – FT4 and triiodothyronine – FT3, and CK concentrations), thyroid ultrasound examination. The associations between irisin, TSH, free thyroid hormones, creatine kinase were analyzed statistically. Furthermore, the difference between irisin serum concentration in hypothyroid and hyperthyroid patients was evaluated. Results: The negative correlation between the irisin and TSH level was demonstrated (r=−0.4924, P=0.023), as well as positive correlation between the irisin and FT4 level (r=0.4833, P=0.036). CK level was negatively correlated with irisin, FT4 and FT3 concentrations (r=−0.7272, P=0,014; r=−0.9636, P≤0.0001; r=−0.8838, P=0.0.0007 respectively). The mean serum irisin level was lower in hypothyroid than hyperthyroid patients, at the border of statistical significance (P=0.0726). Conclusions: Obtained results suggest the influence of thyrometabolic state on irisin concentration; lower irisin level was found in patients with hypothyroidism. This might be explained with muscle destruction, demonstrating with high CK level.
- Open Access
- 22 October 2013
- Published by Springer Nature in Endocrine
- Vol. 46 (2) , 292-9
The calcium-phosphate balance, modulation of thyroid autoimmune processes and other adverse effects connected with thyroid arterial embolization.
- 22 October 2013
- Published by Springer Nature in Endocrine
- Vol. 46 (2) , 292-9
Open AccessThe calcium-phosphate balance, modulation of thyroid autoimmune processes and other adverse effects connected with thyroid arterial embolization.
- 1 January 2012
- Vol. 63 (2) , 138-42
What might cause pain in the thyroid gland? Report of a patient with subacute thyroiditis of atypical presentation.
Subacute granulomatous thyroiditis (SAT), also known as de Quervain's thyroiditis or painful subacute thyroiditis, is the commonest thyroid condition responsible for neck tenderness. Other causes of pain in the thyroid gland should be taken into consideration during differential diagnosis, especially when a patient presents with misleading or equivocal signs and symptoms. We report the case of a 39 year-old woman diagnosed as having SAT whose clinical, biochemical and radiological presentation varied significantly from the common SAT manifestation. A tentative diagnosis of SAT was made based on the presented symptoms, ultrasonography and fine-needle biopsy results. However, biochemical analysis suggested neither inflammatory process nor the presence of thyrotoxicosis. Moreover, technetium scan of the thyroid revealed normal uptake of the isotope and there was neither clinical nor ultasonographic response for corticosteroids. The patient's symptoms, despite being prescribed typical treatment, gradually deteriorated and the pain became increasingly debilitating. Eventually, the patient underwent total thyroidectomy. As a result, she has become free of symptoms, but the macroscopic picture of thyroid gland, noted during the operation, gave a suspicion of neoplastic process. Nevertheless, histological study of flow samples confirmed the tentative diagnosis of de Quervain's thyroiditis, despite all previous findings that were not suggestive of it. This report confirms the likelihood that SAT can present atypically. Additionally, it indicates that surgical treatment may be considered in patients with severe, debilitating, persistent thyroid gland pain connected with SAT clinical course.
- 1 January 2012
- Vol. 63 (2) , 138-42
What might cause pain in the thyroid gland? Report of a patient with subacute thyroiditis of atypical presentation.
Subacute granulomatous thyroiditis (SAT), also known as de Quervain's thyroiditis or painful subacute thyroiditis, is the commonest thyroid condition responsible for neck tenderness. Other causes of pain in the thyroid gland should be taken into consideration during differential diagnosis, especially when a patient presents with misleading or equivocal signs and symptoms. We report the case of a 39 year-old woman diagnosed as having SAT whose clinical, biochemical and radiological presentation varied significantly from the common SAT manifestation. A tentative diagnosis of SAT was made based on the presented symptoms, ultrasonography and fine-needle biopsy results. However, biochemical analysis suggested neither inflammatory process nor the presence of thyrotoxicosis. Moreover, technetium scan of the thyroid revealed normal uptake of the isotope and there was neither clinical nor ultasonographic response for corticosteroids. The patient's symptoms, despite being prescribed typical treatment, gradually deteriorated and the pain became increasingly debilitating. Eventually, the patient underwent total thyroidectomy. As a result, she has become free of symptoms, but the macroscopic picture of thyroid gland, noted during the operation, gave a suspicion of neoplastic process. Nevertheless, histological study of flow samples confirmed the tentative diagnosis of de Quervain's thyroiditis, despite all previous findings that were not suggestive of it. This report confirms the likelihood that SAT can present atypically. Additionally, it indicates that surgical treatment may be considered in patients with severe, debilitating, persistent thyroid gland pain connected with SAT clinical course.